These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35935507)

  • 1. Tips and Tricks and Clinical Outcome of Cryopreserved Human Amniotic Membrane Application for the Management of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Pilot Study.
    Odet S; Meyer C; Gaudet C; Weber E; Quenot J; Derruau S; Laurence S; Bompy L; Girodon M; Chatelain B; Mauprivez C; Brenet E; Kerdjoudj H; Zwetyenga N; Marchetti P; Hatzfeld AS; Toubeau D; Pouthier F; Lafarge X; Redl H; Fenelon M; Fricain JC; Di Pietro R; Ledouble C; Gualdi T; Parmentier AL; Louvrier A; Gindraux F
    Front Bioeng Biotechnol; 2022; 10():936074. PubMed ID: 35935507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature.
    Sacco R; Akintola O; Sacco N; Acocella A; Calasans-Maia MD; Maranzano M; Olate S
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241200
    [No Abstract]   [Full Text] [Related]  

  • 3. Erratum: Tips and tricks and clinical outcome of cryopreserved human amniotic membrane application for the management of medication- related osteonecrosis of the jaw (MRONJ): A pilot study.
    Frontiers Production Office
    Front Bioeng Biotechnol; 2022; 10():1058241. PubMed ID: 36406224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human amniotic membrane application in oral surgery-An
    Odet S; Solecki L; Meyer C; Weber E; Chatelain B; Euvrard E; Barrabé A; Gualdi T; Parmentier AL; Tatu L; Pouthier F; Louvrier A; Gindraux F
    Front Bioeng Biotechnol; 2022; 10():968346. PubMed ID: 36353738
    [No Abstract]   [Full Text] [Related]  

  • 5. Surgical management of stage-2 medication-related osteonecrosis of the jaw with transplantation of human amniotic membrane: Preliminary results.
    Çanakçi FG; Er N; Duygu G; Varol GF
    J Stomatol Oral Maxillofac Surg; 2022 Jun; 123(3):e28-e31. PubMed ID: 34563730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human amniotic membrane: an improvement in the treatment of Medication-related osteonecrosis of the jaw (MRONJ)? A case-control study.
    Ragazzo M; Val M; Montagner G; Trojan D; Fusetti S; Guarda Nardini L
    Cell Tissue Bank; 2022 Mar; 23(1):129-141. PubMed ID: 33856589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to Amniotic Membranes in Maxillofacial Surgery-A Scoping Review.
    Dawiec G; Niemczyk W; Wiench R; Niemczyk S; Skaba D
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674309
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study.
    Otto S; Ristow O; Pache C; Troeltzsch M; Fliefel R; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2016 Aug; 44(8):1073-80. PubMed ID: 27263757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
    Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication-related osteonecrosis of the jaw in oncological patients with skeletal metastases: conservative treatment is effective up to stage 2.
    Coropciuc RG; Grisar K; Aerden T; Schol M; Schoenaers J; Politis C
    Br J Oral Maxillofac Surg; 2017 Oct; 55(8):787-792. PubMed ID: 28760314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocilizumab: Another medication related to osteonecrosis of the jaws? A case report and literature review.
    Sakkas A; Heil S; Kargus S; Rebel M; Mischkowski RA; Thiele OC
    GMS Interdiscip Plast Reconstr Surg DGPW; 2021; 10():Doc03. PubMed ID: 33928006
    [No Abstract]   [Full Text] [Related]  

  • 14. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
    Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw.
    Bullock G; Miller CA; McKechnie A; Hearnden V
    Front Oral Health; 2021; 2():822411. PubMed ID: 35224540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of advanced-platelet rich fibrin (A-PRF) in the management of medication-related osteonecrosis of the jaw (MRONJ): A case report.
    Asfour MAR; Aljoujou AA; Saifo MS; Jabban HAL
    Clin Case Rep; 2023 Nov; 11(11):e8259. PubMed ID: 38028038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of concentrated growth factor (CGF) in the surgical treatment of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a randomized controlled study.
    Yüce MO; Adalı E; Işık G
    Clin Oral Investig; 2021 Jul; 25(7):4529-4541. PubMed ID: 33392802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ).
    Laimer J; Höller A; Pichler U; Engel R; Neururer SB; Egger A; Griesmacher A; Bruckmoser E
    Nutrients; 2021 May; 13(5):. PubMed ID: 34068498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
    Nisi M; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
    J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ).
    Nica DF; Riviș M; Roi CI; Todea CD; Duma VF; Sinescu C
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.